Nick Fox

Prof Nick Fox

Group Leader

Accelerating the development of effective therapies to make a difference for people living with dementia

Biography

Prof Nick Fox is an expert in neuroimaging whose pioneering work in the development and application of magnetic resonance imaging (MRI) methods has had impacts on the detection, diagnosis and monitoring of progression in cognitive disorders and neurodegenerative dementias. 

He is currently Professor of Neurology and Director of the Dementia Research Centre at the Institute of Neurology, University College London. 

He has published over 400 papers, and is recognised as a “most highly cited” researcher by Thomson Reuters (top 1% of global citations in 2017). He has earned numerous prestigious awards, including election to the Fellowship of the Academy of Medical Sciences and NIHR Senior Investigator, and the 2017 Weston Brain Institute International Outstanding Achievement Award.

News

Key publications

Alzheimer's & dementia : the journal of the Alzheimer's Association
Published
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's disease
Authors
Stephanie A Schultz, Yiwen Rao, Lei Liu, Beth Ostaszewski, Amirah K Anderson, Wai-Ying Wendy Yau, Zahra Shirzadi, Brian A Gordon, Jason Hassenstab, John C Morris, Richard J Perrin, Ricardo F Allegri, Nicolas R Barthélemy, Nick Fox, Gregory S Day, Mathias Jucker, Allan I Levey, Johannes Levin, Hiroshi Mori, Stephen Salloway, Peter Schofield, Eric McDade, Reisa A Sperling, Randall J Bateman, Dennis J Selkoe, Jasmeer P Chhatwal, and the Dominantly Inherited Alzheimer's Network
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's disease
medRxiv : the preprint server for health sciences
Published
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
Authors
Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford, Alireza Atri, Susan L Mills, Anna M Santacruz, Guoqiao Wang, Charlene Supnet, Tammie L S Benzinger, Brian A Gordon, Laura Ibanez, Gregory Klein, Monika Baudler, Rachelle S Doody, Paul Delmar, Geoffrey A Kerchner, Tobias Bittner, Jakub Wojtowicz, Azad Bonni, Paulo Fontoura, Carsten Hofmann, Luka Kulic, Jason Hassenstab, Andrew J Aschenbrenner, Richard J Perrin, Carlos Cruchaga, Alan E Renton, Chengjie Xiong, Alison A Goate, John C Morris, David M Holtzman, B Joy Snider, Catherine Mummery, William S Brooks, David Wallon, Sarah B Berman, Erik Roberson, Colin L Masters, Douglas R Galasko, Suman Jayadev, Rachel Sanchez-Valle, Jeremie Pariente, Justin Kinsella, Christopher H van Dyck, Serge Gauthier, Ging-Yuek Robin Hsiung, Mario Masellis, Bruno Dubois, Lawrence S Honig, Clifford R Jack, Alisha Daniels, David Aguillón, Ricardo Allegri, Jasmeer Chhatwal, Gregory Day, Nick Fox, Edward Huey, Takeshi Ikeuchi, Mathias Jucker, Jae-Hong Lee, Allan I Levey, Johannes Levin, Francisco Lopera, JeeHoon Roh, Pedro Rosa-Neto, Peter R Schofield, Dominantly Inherited Alzheimer’s Disease-Trials Unit
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
JAMA Neurol
Published
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.
Authors
Bruno Dubois, Nicolas Villain, Lon Schneider, Nick Fox, Noll Campbell, Douglas Galasko, Miia Kivipelto, Frank Jessen, Bernard Hanseeuw, Mercè Boada, Frederik Barkhof, Agneta Nordberg, Lutz Froelich, Gunhild Waldemar, Kristian Steen Frederiksen, Alessandro Padovani, Vincent Planche, Christopher Rowe, Alexandre Bejanin, Agustin Ibanez, Stefano Cappa, Paulo Caramelli, Ricardo Nitrini, Ricardo Allegri, Andrea Slachevsky, Leonardo Cruz de Souza, Andrea Bozoki, Eric Widera, Kaj Blennow, Craig Ritchie, Marc Agronin, Francisco Lopera, Lisa Delano-Wood, Stéphanie Bombois, Richard Levy, Madhav Thambisetty, Jean Georges, David T Jones, Helen Lavretsky, Jonathan Schott, Jennifer Gatchel, Sandra Swantek, Paul Newhouse, Howard H Feldman, Giovanni B Frisoni
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.

Fox Lab

Explore the work of the Fox Lab, accelerating the development of effective therapies to make a difference people living with dementia

Fox Lab